2021
DOI: 10.3390/genes12050667
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Mild Stress and Venlafaxine Treatment Were Associated with Altered Expression Level and Methylation Status of New Candidate Inflammatory Genes in PBMCs and Brain Structures of Wistar Rats

Abstract: Preclinical studies conducted to date suggest that depression could be elicited by the elevated expression of proinflammatory molecules: these play a key role in the mediation of neurochemical, neuroendocrine and behavioral changes. Thus, this study investigates the effect of chronic mild stress (CMS) and administration of venlafaxine (SSRI) on the expression and methylation status of new target inflammatory genes: TGFA, TGFB, IRF1, PTGS2 and IKBKB, in peripheral blood mononuclear cells (PMBCs) and in selected… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 71 publications
0
5
0
Order By: Relevance
“…The potential value of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs), typically prescribed for anxiety, depression and obsessive-compulsive disorder (OCD), has been discussed significantly in the scientific literature [ 8 ] and lay press [ 9 ]. Numerous in vitro studies have carefully delineated multiple inflammatory pathways in which SSRIs and SNRIs might be beneficial in reducing inflammation [ 10 , 11 , 12 , 13 , 14 ]. The key role of inflammation in the progression, morbidity, and mortality of COVID-19 has been well documented in the medical literature and cytokine storm syndrome is a life-threatening feature of severe COVID-19 [ 8 , 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…The potential value of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs), typically prescribed for anxiety, depression and obsessive-compulsive disorder (OCD), has been discussed significantly in the scientific literature [ 8 ] and lay press [ 9 ]. Numerous in vitro studies have carefully delineated multiple inflammatory pathways in which SSRIs and SNRIs might be beneficial in reducing inflammation [ 10 , 11 , 12 , 13 , 14 ]. The key role of inflammation in the progression, morbidity, and mortality of COVID-19 has been well documented in the medical literature and cytokine storm syndrome is a life-threatening feature of severe COVID-19 [ 8 , 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Smads (including Smad2) are the main signal transductors activated by the TGF-beta signaling (Hiew et al, 2021), which have being implicated in the effects of stress and depression. For example, TGF-beta mRNA expression is reduced in the amygdala of Wistar rats exposed to chronic mild stress (Bialek et al, 2021). Further, chronic treatment of clinically used antidepressants in rodents increases TGF-beta signaling in the frontal cortex and hippocampus (Dow, 2005; Trojan et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…A preclinical study by Białek et al . [ 24 ] confirmed an association between TGF-β gene expression and methylation in depressive disorder. The findings of the current study are that the serum ICAM-1 concentrations were significantly lower in controls than in patients.…”
mentioning
confidence: 87%
“…Similar to our results, the study by Davami et al [23] presented higher concentration of TGFβ in depression compared to controls. A preclinical study by Białek et al [24] confirmed an association between TGF-β gene expression and methylation in depressive disorder. The findings of the current study are that the serum ICAM-1 concentrations were significantly lower in controls than in patients.…”
mentioning
confidence: 90%
See 1 more Smart Citation